AOD-9604 studies
20 journal papers mention AOD-9604 in the title or abstract. Here are the most cited, the latest, and a few facts about the literature.
Studies range from laboratory work to clinical trials. A paper listed here is not an endorsement and says nothing about whether AOD-9604 is safe, effective or approved for any use.
- Papers
- 20
- 17 articles, 3 reviews
- Earliest paper
- 2000
- Most papers in 2014 (4)
- Open access
- 45%
- free to read somewhere
- Reviews
- 15%
- of all papers listed
What kind of studies
Of 22 papers in PubMed that mention AOD-9604 in the title or abstract, by the study type PubMed records. Categories overlap, so they do not add up to the total.
- Randomized controlled trials0
- Other clinical trials0
- Meta-analyses and systematic reviews0
- Other reviews9
- Case reports0
- Animal studies only3
- Studies in humans18
Study types are tags assigned by publishers and PubMed indexers; very new papers are often not tagged yet, and a tag is not a quality rating. Retracted papers are excluded. Source: PubMed (NCBI).
Papers per year
2000 to 2026, peak 4 papers in a year. The latest year may still be incomplete.
Where it is published
- Journal of Endocrinology and Metabolism4 papers
- Inpharma Weekly2 papers
- Endocrinology2 papers
- International Journal of Obesity1 papers
- Bone1 papers
The papers
Most citedName in the title
- The Effects of Human GH and Its Lipolytic Fragment (AOD9604) on Lipid Metabolism Following Chronic Treatment in Obese Mice andβ 3-AR Knock-Out Mice
Mark Heffernan, Roger J. Summers, Anne W. Thorburn et al. · Endocrinology · 2001
Study in humans31 citations
- Metabolic Studies of a Synthetic Lipolytic Domain (AOD9604) of Human Growth Hormone
F M Ng, Jie Sun, L. Sharma et al. · Hormone Research in Paediatrics · 2000
Animal study25 citations
- Identification and characterization of peptide drugs in unknown pharmaceutical preparations seized by the Belgian authorities: case report on AOD9604
Céline Vanhee, Goedele Moens, Eric Deconinck et al. · Drug Testing and Analysis · 2014
15 citations
- The Effects of Human GH and Its Lipolytic Fragment (AOD9604) on Lipid Metabolism Following Chronic Treatment in Obese Mice and 3-AR Knock-Out Mice
M. Heffernan · Endocrinology · 2001
12 citations
- Safety and Tolerability of the Hexadecapeptide AOD9604 in Humans
Heike Stier, Evert Vos, David Kenley · Journal of Endocrinology and Metabolism · 2013
Open access10 citationsRead the open copy →
- Safety and Tolerability of the Hexadecapeptide AOD9604 in Humans
Stier · Journal of Endocrinology and Metabolism · 2013
Open access · CC BY-NC6 citationsRead the open copy →
- Safety and Metabolism of AOD9604, a Novel Nutraceutical Ingredient for Improved Metabolic Health
Margret Irmgard Moré, David Kenley · Journal of Endocrinology and Metabolism · 2014
Open access4 citationsRead the open copy →
- Safety and Metabolism of AOD9604, a Novel Nutraceutical Ingredient for Improved Metabolic Health
Moré · Journal of Endocrinology and Metabolism · 2014
Open access · CC BY-NC2 citationsRead the open copy →
- The Effect of Eight Weeks Endurance Training, Somatropin Injection, and Its Lipolytic Fragment (AOD9604) on Cytokeratin-18 and Liver Enzymes of Mice Induced Liver Damage Due to a High-Fat Diet
Mohsen Dehbashi, Mehrdad Fathi, Seyed Reza Attarzadeh Hosseini et al. · Quarterly of Horizon of Medical Sciences · 2021
Open access · CC BY-NCRead the open copy →
- اثر هشت هفته تمرین استقامتی و تزریق قطعه لیپولیتیک هورمون رشد (AOD9604) بر آنزیمهای کبد و CK18 موشهای سوری القاء شده به کبد چرب غیرالکلی ناشی از رژیم غذایی پر چرب
Mohsen Dehbashi, Mehrdad Fathie, Seyyed Reza Attarzadeh Hosseini et al. · مجله دانش و تندرستي در علوم پایه پزشکی · 2021
- Does the growth hormone-derived peptide AOD9604 have an anabolic effect on bone?
I. Kamikovski, Richard Renlund, Marc D. Grynpas · Bone · 2009
- The orally active peptide AOD 9604* may aid weight reduction in obese subjects,
&NA; · Inpharma Weekly · 2005
- The anti-obesity drug AOD-9604* has demonstrated favourable safety and tolerability in a phase II clinical trial.
&NA; · Inpharma Weekly · 2003
- The use of proteomics to understand the action of the Anti-Obestty Compound AOD9604 in the treatment of obesity
Roksan Libinaki, Robert Gianello, Esra Ogru et al. · Biochemical Society Transactions · 2000
LatestName in title or abstract
- The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration
Aleksander Dominikowski, Zofia Rękoś, Michał Olejarz et al. · Frontiers in Endocrinology · 2026
ReviewOpen access · CC BY1 citationsRead the open copy →
- Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions
Omar F. Rahman, Steven J. Lee, William A. Seeds · JAAOS Global Research and Reviews · 2026
ReviewOpen access · CC BY-NC-ND5 citationsRead the open copy →
- The Effect of Eight Weeks Endurance Training, Somatropin Injection, and Its Lipolytic Fragment (AOD9604) on Cytokeratin-18 and Liver Enzymes of Mice Induced Liver Damage Due to a High-Fat Diet
Mohsen Dehbashi, Mehrdad Fathi, Seyed Reza Attarzadeh Hosseini et al. · Quarterly of Horizon of Medical Sciences · 2021
Open access · CC BY-NCRead the open copy →
- اثر هشت هفته تمرین استقامتی و تزریق قطعه لیپولیتیک هورمون رشد (AOD9604) بر آنزیمهای کبد و CK18 موشهای سوری القاء شده به کبد چرب غیرالکلی ناشی از رژیم غذایی پر چرب
Mohsen Dehbashi, Mehrdad Fathie, Seyyed Reza Attarzadeh Hosseini et al. · مجله دانش و تندرستي در علوم پایه پزشکی · 2021
- Safety and Metabolism of AOD9604, a Novel Nutraceutical Ingredient for Improved Metabolic Health
Margret Irmgard Moré, David Kenley · Journal of Endocrinology and Metabolism · 2014
Open access4 citationsRead the open copy →
- Identification and characterization of peptide drugs in unknown pharmaceutical preparations seized by the Belgian authorities: case report on AOD9604
Céline Vanhee, Goedele Moens, Eric Deconinck et al. · Drug Testing and Analysis · 2014
15 citations
- Pharmacological management of obesity: Past, present and future
Mohammed Habibuddin, Touseef Humaira · Saudi Journal of Obesity · 2014
Open access · CC BY-NC-SA2 citationsRead the open copy →
- Safety and Metabolism of AOD9604, a Novel Nutraceutical Ingredient for Improved Metabolic Health
Moré · Journal of Endocrinology and Metabolism · 2014
Open access · CC BY-NC2 citationsRead the open copy →
- Safety and Tolerability of the Hexadecapeptide AOD9604 in Humans
Heike Stier, Evert Vos, David Kenley · Journal of Endocrinology and Metabolism · 2013
Open access10 citationsRead the open copy →
- Safety and Tolerability of the Hexadecapeptide AOD9604 in Humans
Stier · Journal of Endocrinology and Metabolism · 2013
Open access · CC BY-NC6 citationsRead the open copy →
- Current Updates in the Medical Management of Obesity
Areej Umber Khan, Shahzad Raza, Yusra Khan et al. · Recent Patents on Endocrine Metabolic & Immune Drug Discovery · 2012
Review25 citations
- Does the growth hormone-derived peptide AOD9604 have an anabolic effect on bone?
I. Kamikovski, Richard Renlund, Marc D. Grynpas · Bone · 2009
- Potential Role of New Therapies in Modifying Cardiovascular Risk in Overweight Patients with Metabolic Risk Factors
Michael D. Jensen · Obesity · 2006
ReviewOpen access15 citationsRead the open copy →
- The orally active peptide AOD 9604* may aid weight reduction in obese subjects,
&NA; · Inpharma Weekly · 2005
- The anti-obesity drug AOD-9604* has demonstrated favourable safety and tolerability in a phase II clinical trial.
&NA; · Inpharma Weekly · 2003
- The Effects of Human GH and Its Lipolytic Fragment (AOD9604) on Lipid Metabolism Following Chronic Treatment in Obese Mice andβ 3-AR Knock-Out Mice
Mark Heffernan, Roger J. Summers, Anne W. Thorburn et al. · Endocrinology · 2001
Study in humans31 citations
- The Effects of Human GH and Its Lipolytic Fragment (AOD9604) on Lipid Metabolism Following Chronic Treatment in Obese Mice and 3-AR Knock-Out Mice
M. Heffernan · Endocrinology · 2001
12 citations
- Increase of fat oxidation and weight loss in obese mice caused by chronic treatment with human growth hormone or a modified C-terminal fragment
MA Heffernan, A W Thorburn, Barbara Christianne Fam et al. · International Journal of Obesity · 2001
Animal study36 citations
- The use of proteomics to understand the action of the Anti-Obestty Compound AOD9604 in the treatment of obesity
Roksan Libinaki, Robert Gianello, Esra Ogru et al. · Biochemical Society Transactions · 2000
- Metabolic Studies of a Synthetic Lipolytic Domain (AOD9604) of Human Growth Hormone
F M Ng, Jie Sun, L. Sharma et al. · Hormone Research in Paediatrics · 2000
Animal study25 citations
Each list shows up to 40 papers.See all 20 on OpenAlex. Source: OpenAlex (CC0), journal articles and reviews with a DOI, retractions excluded, refreshed weekly, last 4 Nov 2026, 08:31 UTC. Papers are listed by their metadata only; follow the links to read them. A license shown on an open copy is the license the publisher or repository states for that copy.